Table 2.
Group | Procedure |
---|---|
LB + DEX IV | 2 × EX of up to four teeth on R MAX, 2 × EX of up to four teeth on L MAX, 3 × EX of up to four teeth on L MAN, multi EX, GG on L + R MAN, PCP of C on R MAN |
LB + PLC IV | 2 × EX of up to four teeth on L MAX, EX of up to four teeth on L MAN, 3 × multi EX, multi EX with full-mouth GG, PCP of C on L MAN, PCP of C on L + R MAN, ENDO of C on L MAX |
LB + DEX IO | EX of up to four teeth on R MAX, 2 × EX of up to four teeth on L MAX, EX of up to four teeth on L + R MAX, EX of up to four teeth on L MAN, EX of up to four teeth on R MAN with IPP on L + R MAX, 2 × multi EX, PCP of C on L + R MAN, ENDO of C on L MAN |
LB + DEX IA | EX of up to four teeth on R MAX, 2 × EX of up to four teeth on L + R MAX, EX of up to four teeth on L MAN, 2 x EX of up to four teeth on R MAN, 3 × multi EX, ENDO of C on L MAN |
C, canine tooth; ENDO, endodontic procedure; EX, extraction; GG, gingivectomy; IPP, inclined plane placement; L, left; LB + DEX IA, dogs (n = 10) which received levobupivacaine and dexmedetomidine perineurally into the submucosa at the opening of the mandibular foramen; LB + DEX IO, dogs (n = 10) which received levobupivacaine and dexmedetomidine perineurally into the infraorbital canal; LB + DEX IV, dogs (n = 10) which received levobupivacaine perineurally and dexmedetomidine IV (positive control); LB + PLC IV, dogs (n = 10) which received levobupivacaine perineurally and placebo IV (negative control); MAN, mandibula; MAX, maxilla; multi EX, multiple extractions (five or more teeth extracted on all four quadrants); PCP, partial coronal pulpectomy; R, right.